| Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1 | Blood | 2000 | 582 |
| Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake | Journal of Clinical Investigation | 2006 | 406 |
| Chronic Lymphocytic Leukemia B Cells Express Functional CXCR4 Chemokine Receptors That Mediate Spontaneous Migration Beneath Bone Marrow Stromal Cells | Blood | 1999 | 391 |
| Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation | Nature Chemical Biology | 2015 | 354 |
| Mutation analysis in hereditary hemochromatosis | Blood Cells, Molecules, and Diseases | 1996 | 306 |
| A cell cycle-regulated inhibitor of cyclin-dependent kinases | Proceedings of the National Academy of Sciences of the United States of America | 1994 | 251 |
| Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine | Medical Physics | 1999 | 228 |
| Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis | Cancer Research | 2014 | 219 |
| Extended follow-up of patients with hairy cell leukemia after treatment with cladribine | Journal of Clinical Oncology | 2003 | 218 |
| Signaling of the tissue factor coagulation pathway in angiogenesis and cancer | Arteriosclerosis, Thrombosis, and Vascular Biology | 2005 | 185 |
| Activated protein C: biased for translation | Blood | 2015 | 156 |
| 2-Chlorodeoxyadenosine treatment of low-grade lymphomas | Journal of Clinical Oncology | 1992 | 148 |
| Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand | Biochemistry | 2006 | 144 |
| Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients | Journal of Clinical Oncology | 2004 | 124 |
| Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis | Molecular and Cellular Biology | 2005 | 123 |
| Newer purine analogues for the treatment of hairy-cell leukemia | New England Journal of Medicine | 1994 | 115 |
| Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice | Proceedings of the National Academy of Sciences of the United States of America | 1995 | 112 |
| The role of platelets in ischemic stroke | Neurology | 1998 | 103 |
| Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73) | Tissue Antigens | 1990 | 102 |
| 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia | Leukemia and Lymphoma | 1991 | 100 |
| 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia | Journal of Clinical Oncology | 1995 | 99 |
| A phase I/II trial of nimodipine for HIV-related neurologic complications | Neurology | 1998 | 98 |
| 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T- cell lymphoma | Blood | 1992 | 95 |
| Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B | Journal of Clinical Oncology | 1994 | 89 |
| Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53 | Cancer Research | 2013 | 85 |
